Concepts (70)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Warfarin | 2 | 2006 | 93 | 0.320 |
Why?
|
Insect Hormones | 1 | 2006 | 1 | 0.270 |
Why?
|
Herb-Drug Interactions | 1 | 2006 | 5 | 0.270 |
Why?
|
Hematuria | 1 | 2006 | 24 | 0.270 |
Why?
|
Fatty Acids | 1 | 2006 | 222 | 0.250 |
Why?
|
Ambulatory Care | 2 | 2005 | 340 | 0.250 |
Why?
|
Anticoagulants | 1 | 2006 | 356 | 0.220 |
Why?
|
Students, Medical | 1 | 2003 | 210 | 0.190 |
Why?
|
Internet | 1 | 2003 | 390 | 0.180 |
Why?
|
Internship and Residency | 1 | 2003 | 596 | 0.150 |
Why?
|
Data Collection | 2 | 2003 | 420 | 0.100 |
Why?
|
Patient Education as Topic | 2 | 2005 | 425 | 0.100 |
Why?
|
Diabetes Mellitus | 2 | 2005 | 694 | 0.080 |
Why?
|
Medical Records, Problem-Oriented | 1 | 2006 | 10 | 0.070 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 240 | 0.070 |
Why?
|
Pharmaceutical Services | 1 | 2005 | 47 | 0.060 |
Why?
|
Pharmacy Service, Hospital | 1 | 2005 | 52 | 0.060 |
Why?
|
Pain | 1 | 2008 | 472 | 0.060 |
Why?
|
Propylamines | 1 | 2004 | 22 | 0.060 |
Why?
|
Azithromycin | 1 | 2004 | 13 | 0.060 |
Why?
|
Coronary Disease | 1 | 2006 | 358 | 0.060 |
Why?
|
Education, Pharmacy | 1 | 2005 | 102 | 0.060 |
Why?
|
Accreditation | 1 | 2002 | 72 | 0.050 |
Why?
|
Chi-Square Distribution | 1 | 2003 | 546 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2006 | 4848 | 0.050 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2004 | 189 | 0.050 |
Why?
|
Pharmacists | 1 | 2002 | 125 | 0.050 |
Why?
|
Clinical Competence | 1 | 2005 | 657 | 0.040 |
Why?
|
Humans | 9 | 2008 | 68618 | 0.040 |
Why?
|
Male | 6 | 2006 | 37321 | 0.030 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2008 | 37 | 0.020 |
Why?
|
Fibromyalgia | 1 | 2008 | 29 | 0.020 |
Why?
|
Low Back Pain | 1 | 2008 | 45 | 0.020 |
Why?
|
Gastrointestinal Tract | 1 | 2008 | 63 | 0.020 |
Why?
|
Osteoarthritis | 1 | 2008 | 73 | 0.020 |
Why?
|
Cardiovascular System | 1 | 2008 | 85 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 1 | 2008 | 157 | 0.020 |
Why?
|
Medical Audit | 1 | 2006 | 44 | 0.020 |
Why?
|
Adult | 4 | 2006 | 21403 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 2006 | 219 | 0.020 |
Why?
|
Female | 5 | 2006 | 38074 | 0.020 |
Why?
|
Hypolipidemic Agents | 1 | 2006 | 82 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2005 | 161 | 0.020 |
Why?
|
Atomoxetine Hydrochloride | 1 | 2004 | 14 | 0.020 |
Why?
|
Half-Life | 1 | 2004 | 96 | 0.020 |
Why?
|
Intestinal Absorption | 1 | 2004 | 41 | 0.020 |
Why?
|
International Normalized Ratio | 1 | 2004 | 23 | 0.010 |
Why?
|
Aged | 3 | 2006 | 14862 | 0.010 |
Why?
|
Lipids | 1 | 2006 | 298 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2004 | 282 | 0.010 |
Why?
|
Area Under Curve | 1 | 2004 | 238 | 0.010 |
Why?
|
Lipoproteins, LDL | 1 | 2006 | 343 | 0.010 |
Why?
|
Drug Interactions | 1 | 2004 | 289 | 0.010 |
Why?
|
Patient Compliance | 1 | 2006 | 402 | 0.010 |
Why?
|
Chronic Disease | 1 | 2008 | 1330 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2006 | 7029 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2005 | 322 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2004 | 649 | 0.010 |
Why?
|
Middle Aged | 3 | 2006 | 21147 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2005 | 442 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2004 | 931 | 0.010 |
Why?
|
Blood Pressure | 1 | 2005 | 1451 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2004 | 1851 | 0.010 |
Why?
|
Pregnancy | 1 | 2004 | 2334 | 0.010 |
Why?
|
South Carolina | 1 | 2005 | 2752 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2006 | 7277 | 0.010 |
Why?
|
Child | 1 | 2004 | 6405 | 0.010 |
Why?
|
Adolescent | 1 | 2004 | 8912 | 0.010 |
Why?
|
United States | 1 | 2002 | 7367 | 0.010 |
Why?
|
Animals | 1 | 2004 | 20881 | 0.000 |
Why?
|